{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:22:24Z","timestamp":1790446944192,"version":"4.1.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00011-025-02037-0","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T05:55:51Z","timestamp":1745906151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Nrf2 mediated signaling axis in sepsis-induced cardiomyopathy: potential Pharmacological receptor"],"prefix":"10.1007","volume":"74","author":[{"given":"Sumei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"8","key":"2037_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for Sepsis and septic shock (Sepsis-3)[J]. JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"key":"2037_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"E Rudd Kristina","year":"2020","unstructured":"Rudd Kristina E, Johnson S, Charlotte, Agesa Kareha M, et al. Global, regional, and National sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease Study[J]. Lancet. 2020;395:200\u201311.","journal-title":"Lancet"},{"key":"2037_CR3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.7326\/0003-4819-100-4-483","volume":"100","author":"MM Parker","year":"1984","unstructured":"Parker MM, Shelhamer JH, Bacharach SL, et al. Profound but reversible myocardial depression in patients with septic shock[J]. Ann Intern Med. 1984;100:483\u201390.","journal-title":"Ann Intern Med"},{"key":"2037_CR4","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s00134-015-3970-3","volume":"41","author":"CW-TLW-HL Wei-Ting","year":"2015","unstructured":"Wei-Ting CW-TLW-HL, et al. Left ventricular global longitudinal strain is independently associated with mortality in septic shock patients[J]. Intensive Care Med. 2015;41:1791\u20139.","journal-title":"Intensive Care Med"},{"key":"2037_CR5","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.3346\/jkms.2020.35.e24","volume":"35","author":"LJ Kim Sua","year":"2020","unstructured":"Kim Sua LJ, Dong KB, Ki, et al. Association between left ventricular systolic dysfunction and mortality in patients with septic Shock[J]. J Korean Med Sci. 2020;35:e24.","journal-title":"J Korean Med Sci"},{"key":"2037_CR6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41569-020-00492-2","volume":"18","author":"M Hollenberg Steven","year":"2021","unstructured":"Hollenberg Steven M, Singer M. Pathophysiology of sepsis-induced cardiomyopathy[J]. Nat Rev Cardiol. 2021;18:424\u201334.","journal-title":"Nat Rev Cardiol"},{"key":"2037_CR7","doi-asserted-by":"publisher","first-page":"101771","DOI":"10.1016\/j.redox.2020.101771","volume":"38","author":"Y Li","year":"2021","unstructured":"Li Y, Feng YF, Liu XT, et al. Songorine promotes cardiac mitochondrial biogenesis via Nrf2 induction during sepsis. Redox Biol. 2021;38:101771. https:\/\/doi.org\/10.1016\/j.redox.2020.101771.","journal-title":"Redox Biol"},{"issue":"2","key":"2037_CR8","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/ptr.8093","volume":"38","author":"Z Fang","year":"2024","unstructured":"Fang Z, Wang G, Huang R, et al. Astilbin protects from sepsis-induced cardiac injury through the NRF2\/HO-1 and TLR4\/NF-\u03baB pathway. Phytother Res. 2024;38(2):1044\u201358. https:\/\/doi.org\/10.1002\/ptr.8093.","journal-title":"Phytother Res"},{"issue":"1","key":"2037_CR9","doi-asserted-by":"publisher","first-page":"2157521","DOI":"10.1080\/08941939.2022.2157521","volume":"36","author":"Y Zeng","year":"2023","unstructured":"Zeng Y, Cao G, Lin L, et al. Resveratrol attenuates Sepsis-Induced cardiomyopathy in rats through Anti-Ferroptosis via the Sirt1\/Nrf2 pathway. J Invest Surg. 2023;36(1):2157521. https:\/\/doi.org\/10.1080\/08941939.2022.2157521.","journal-title":"J Invest Surg"},{"issue":"9","key":"2037_CR10","doi-asserted-by":"publisher","first-page":"300060522111868","DOI":"10.1177\/03000605221118680","volume":"50","author":"W Guo","year":"2022","unstructured":"Guo W, Long X, Lv M, et al. Effect of thymoquinone on sepsis-induced cardiac damage via anti-inflammatory and anti-apoptotic mechanisms. J Int Med Res. 2022;50(9):3000605221118680. https:\/\/doi.org\/10.1177\/03000605221118680.","journal-title":"J Int Med Res"},{"issue":"2","key":"2037_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00210-020-01972-5","volume":"394","author":"I Rahim","year":"2021","unstructured":"Rahim I, Sayed RK, Fern\u00e1ndez-Ortiz M, et al. Melatonin alleviates sepsis-induced heart injury through activating the Nrf2 pathway and inhibiting the NLRP3 inflammasome. Naunyn Schmiedebergs Arch Pharmacol. 2021;394(2):261\u201377. https:\/\/doi.org\/10.1007\/s00210-020-01972-5.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"2037_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/FJC.0000000000000989","volume":"77","author":"L Xingyue","year":"2021","unstructured":"Xingyue L, Shuang L, Qiang W, et al. Chrysin ameliorates Sepsis-Induced cardiac dysfunction through upregulating Nfr2\/Heme Oxygenase 1 pathway. J Cardiovasc Pharmacol. 2021;77(4):491\u2013500. https:\/\/doi.org\/10.1097\/FJC.0000000000000989.","journal-title":"J Cardiovasc Pharmacol"},{"key":"2037_CR13","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fphys.2020.00514","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang Y, Yu W, Shi C, et al. Crocetin attenuates Sepsis-Induced cardiac dysfunction via regulation of inflammatory response and mitochondrial function. Front Physiol. 2020;11:514. https:\/\/doi.org\/10.3389\/fphys.2020.00514. Published 2020 Jun 9.","journal-title":"Front Physiol"},{"key":"2037_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02015","author":"J Chen","year":"2018","unstructured":"Chen J, Wang B, Lai J, et al. Trimetazidine Attenuates Cardiac Dysfunction in Endotoxemia and Sepsis by Promoting Neutrophil Migration. Front Immunol. 2018;9. https:\/\/doi.org\/10.3389\/fimmu.2018.02015. Published 2018 Sep 4.:2015."},{"issue":"Pt A","key":"2037_CR15","doi-asserted-by":"publisher","first-page":"111038","DOI":"10.1016\/j.intimp.2023.111038","volume":"125","author":"X Zhao","year":"2023","unstructured":"Zhao X, Liu Y, Han X, et al. Dapagliflozin attenuates the vulnerability to atrial fibrillation in rats with lipopolysaccharide-induced myocardial injury. Int Immunopharmacol. 2023;125(Pt A):111038. https:\/\/doi.org\/10.1016\/j.intimp.2023.111038.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"2037_CR16","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.25122\/jml-2023-0015","volume":"16","author":"SMH Hadi","year":"2023","unstructured":"Hadi SMH, Majeed S, Ghafil FA, et al. Effect of Sulforaphane on cardiac injury induced by sepsis in a mouse model: role of toll-like receptor 4. J Med Life. 2023;16(7):1120\u20136. https:\/\/doi.org\/10.25122\/jml-2023-0015.","journal-title":"J Med Life"},{"issue":"2","key":"2037_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1248\/cpb.c19-00646","volume":"68","author":"MQ Zhou","year":"2020","unstructured":"Zhou MQ, Jin E, Wu J, et al. CTRP12 ameliorated Lipopolysaccharide-Induced cardiomyocyte injury. Chem Pharm Bull (Tokyo). 2020;68(2):133\u20139. https:\/\/doi.org\/10.1248\/cpb.c19-00646.","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"2037_CR18","doi-asserted-by":"publisher","first-page":"174522","DOI":"10.1016\/j.ejphar.2021.174522","volume":"911","author":"J Feng","year":"2021","unstructured":"Feng J, Liu Z, Chen H, et al. Protective effect of Cynaroside on sepsis-induced multiple organ injury through Nrf2\/HO-1-dependent macrophage polarization. Eur J Pharmacol. 2021;911:174522. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174522.","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"2037_CR19","doi-asserted-by":"publisher","first-page":"e28501","DOI":"10.1016\/j.heliyon.2024.e28501","volume":"10","author":"D Hou","year":"2024","unstructured":"Hou D, Liao H, Hao S, et al. Curcumin simultaneously improves mitochondrial dynamics and myocardial cell bioenergy after sepsis via the SIRT1-DRP1\/PGC-1\u03b1 pathway. Heliyon. 2024;10(7):e28501. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28501. Published 2024 Mar 28.","journal-title":"Heliyon"},{"issue":"5","key":"2037_CR20","first-page":"1422","volume":"10","author":"D Liang","year":"2018","unstructured":"Liang D, Huang A, Jin Y, et al. Protective effects of exogenous NaHS against sepsis-induced myocardial mitochondrial injury by enhancing the PGC-1\u03b1\/NRF2 pathway and mitochondrial biosynthesis in mice. Am J Transl Res. 2018;10(5):1422\u201330.","journal-title":"Am J Transl Res"},{"key":"2037_CR21","doi-asserted-by":"publisher","first-page":"111001","DOI":"10.1016\/j.cellsig.2023.111001","volume":"114","author":"Z Dan","year":"2024","unstructured":"Dan Z, Shi X, Shu C, et al. 4-amino-2-trifluoromethyl-phenyl retinate alleviates lipopolysaccharide-induced acute myocardial injury through activation of the KLF4\/p62 axis. Cell Signal. 2024;114:111001. https:\/\/doi.org\/10.1016\/j.cellsig.2023.111001.","journal-title":"Cell Signal"},{"key":"2037_CR22","doi-asserted-by":"publisher","first-page":"109067","DOI":"10.1016\/j.intimp.2022.109067","volume":"111","author":"W Jian","year":"2022","unstructured":"Jian W, Ma H, Wang D, et al. Omaveloxolone attenuates the sepsis-induced cardiomyopathy via activating the nuclear factor erythroid 2-related factor 2. Int Immunopharmacol. 2022;111:109067. https:\/\/doi.org\/10.1016\/j.intimp.2022.109067.","journal-title":"Int Immunopharmacol"},{"key":"2037_CR23","doi-asserted-by":"publisher","first-page":"175745","DOI":"10.1016\/j.ejphar.2023.175745","volume":"950","author":"Y Fu","year":"2023","unstructured":"Fu Y, Zhang HJ, Zhou W, et al. The protective effects of Sophocarpine on sepsis-induced cardiomyopathy. Eur J Pharmacol. 2023;950:175745. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175745.","journal-title":"Eur J Pharmacol"},{"key":"2037_CR24","doi-asserted-by":"publisher","first-page":"709604","DOI":"10.3389\/fphar.2021.709604","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Zhang L, Zhang P, et al. Dehydrocorydaline protects against Sepsis-Induced myocardial injury through modulating the TRAF6\/NF-\u03baB pathway. Front Pharmacol. 2021;12:709604. https:\/\/doi.org\/10.3389\/fphar.2021.709604. Published 2021 Aug 19.","journal-title":"Front Pharmacol"},{"issue":"3","key":"2037_CR25","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41401-020-0397-3","volume":"42","author":"Y Tan","year":"2021","unstructured":"Tan Y, Wan HH, Sun MM, et al. Cardamonin protects against lipopolysaccharide-induced myocardial contractile dysfunction in mice through Nrf2-regulated mechanism. Acta Pharmacol Sin. 2021;42(3):404\u201313. https:\/\/doi.org\/10.1038\/s41401-020-0397-3.","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"2037_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.15586\/aei.v51i1.813","volume":"51","author":"D Wu","year":"2023","unstructured":"Wu D, Yuan R, Zhang L, et al. USP13 reduces septic mediated cardiomyocyte oxidative stress and inflammation by inducing Nrf2. Allergol Immunopathol (Madr). 2023;51(2):160\u20137. https:\/\/doi.org\/10.15586\/aei.v51i1.813. Published 2023 Mar 1.","journal-title":"Allergol Immunopathol (Madr)"},{"key":"2037_CR27","doi-asserted-by":"publisher","unstructured":"Hao E, Lang F, Chen Y et al. Resveratrol alleviates endotoxin-induced myocardial toxicity via the Nrf2 transcription factor. PLoS One. 2013;8(7):e69452. Published 2013 Jul 22. https:\/\/doi.org\/10.1371\/journal.pone.0069452","DOI":"10.1371\/journal.pone.0069452"},{"issue":"4","key":"2037_CR28","doi-asserted-by":"publisher","first-page":"H1051","DOI":"10.1152\/ajpheart.00296.2016","volume":"311","author":"T Bai","year":"2016","unstructured":"Bai T, Hu X, Zheng Y, et al. Resveratrol protects against lipopolysaccharide-induced cardiac dysfunction by enhancing SERCA2a activity through promoting the phospholamban oligomerization. Am J Physiol Heart Circ Physiol. 2016;311(4):H1051\u201362. https:\/\/doi.org\/10.1152\/ajpheart.00296.2016.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2037_CR29","doi-asserted-by":"publisher","first-page":"119467","DOI":"10.1016\/j.lfs.2021.119467","volume":"277","author":"D Li","year":"2021","unstructured":"Li D, Wang M, Ye J, et al. Maresin 1 alleviates the inflammatory response, reduces oxidative stress and protects against cardiac injury in LPS-induced mice. Life Sci. 2021;277:119467. https:\/\/doi.org\/10.1016\/j.lfs.2021.119467.","journal-title":"Life Sci"},{"issue":"3","key":"2037_CR30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/bph.13386","volume":"173","author":"J Chen","year":"2016","unstructured":"Chen J, Lai J, Yang L, et al. Trimetazidine prevents macrophage-mediated septic myocardial dysfunction via activation of the histone deacetylase Sirtuin 1. Br J Pharmacol. 2016;173(3):545\u201361. https:\/\/doi.org\/10.1111\/bph.13386.","journal-title":"Br J Pharmacol"},{"issue":"9","key":"2037_CR31","doi-asserted-by":"publisher","first-page":"e13910","DOI":"10.1111\/1440-1681.13910","volume":"51","author":"Y Wang","year":"2024","unstructured":"Wang Y, Feng W, Li S, et al. Oxycodone attenuates lipopolysaccharide-induced myocardial injury by inhibiting inflammation, oxidation and pyroptosis via Nrf2\/HO-1 signalling pathway. Clin Exp Pharmacol Physiol. 2024;51(9):e13910. https:\/\/doi.org\/10.1111\/1440-1681.13910.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"7","key":"2037_CR32","doi-asserted-by":"publisher","first-page":"e2300576","DOI":"10.1002\/adbi.202300576","volume":"8","author":"H Miao","year":"2024","unstructured":"Miao H, Tang X, Cui Y, et al. Obeticholic acid inhibit mitochondria dysfunction via regulating ERK1\/2-DRP pathway to exert protective effect on Lipopolysaccharide-Induced myocardial injury. Adv Biol (Weinh). 2024;8(7):e2300576. https:\/\/doi.org\/10.1002\/adbi.202300576.","journal-title":"Adv Biol (Weinh)"},{"issue":"8","key":"2037_CR33","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1128\/MCB.26.8.2887-2900.2006","volume":"26","author":"KI Tong","year":"2006","unstructured":"Tong KI, Katoh Y, Kusunoki H, et al. Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol Cell Biol. 2006;26(8):2887\u2013900. https:\/\/doi.org\/10.1128\/MCB.26.8.2887-2900.2006.","journal-title":"Mol Cell Biol"},{"issue":"32","key":"2037_CR34","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1038\/onc.2012.388","volume":"32","author":"S Chowdhry","year":"2013","unstructured":"Chowdhry S, Zhang Y, McMahon M, et al. Nrf2 is controlled by two distinct \u03b2-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. Oncogene. 2013;32(32):3765\u201381. https:\/\/doi.org\/10.1038\/onc.2012.388.","journal-title":"Oncogene"},{"issue":"10","key":"2037_CR35","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.freeradbiomed.2004.02.075","volume":"36","author":"K Itoh","year":"2004","unstructured":"Itoh K, Tong KI, Yamamoto M. Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med. 2004;36(10):1208\u201313. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2004.02.075.","journal-title":"Free Radic Biol Med"},{"issue":"Pt B","key":"2037_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.freeradbiomed.2015.05.034","volume":"88","author":"P Canning","year":"2015","unstructured":"Canning P, Sorrell FJ, Bullock AN. Structural basis of Keap1 interactions with Nrf2. Free Radic Biol Med. 2015;88(Pt B):101\u20137. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.05.034.","journal-title":"Free Radic Biol Med"},{"issue":"24","key":"2037_CR37","doi-asserted-by":"publisher","first-page":"10895","DOI":"10.1128\/MCB.25.24.10895-10906.2005","volume":"25","author":"P Nioi","year":"2005","unstructured":"Nioi P, Nguyen T, Sherratt PJ, et al. The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation. Mol Cell Biol. 2005;25(24):10895\u2013906. https:\/\/doi.org\/10.1128\/MCB.25.24.10895-10906.2005.","journal-title":"Mol Cell Biol"},{"issue":"10","key":"2037_CR38","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1158\/0008-5472.CAN-12-3386","volume":"73","author":"H Wang","year":"2013","unstructured":"Wang H, Liu K, Geng M, et al. RXR\u03b1 inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2. Cancer Res. 2013;73(10):3097\u2013108. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-3386.","journal-title":"Cancer Res"},{"issue":"2","key":"2037_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1152\/physiolgenomics.00041.2017","volume":"50","author":"QM Chen","year":"2018","unstructured":"Chen QM, Maltagliati AJ. Nrf2 at the heart of oxidative stress and cardiac protection. Physiol Genomics. 2018;50(2):77\u201397. https:\/\/doi.org\/10.1152\/physiolgenomics.00041.2017.","journal-title":"Physiol Genomics"},{"issue":"12","key":"2037_CR40","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.3390\/biom10121688","volume":"10","author":"S Gunne","year":"2020","unstructured":"Gunne S, Heinicke U, Parnham MJ, et al. Nrf2-A molecular target for Sepsis patients in critical care. Biomolecules. 2020;10(12):1688.","journal-title":"Biomolecules"},{"issue":"5","key":"2037_CR41","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/med.21396","volume":"36","author":"MC Lu","year":"2016","unstructured":"Lu MC, Ji JA, Jiang ZY, et al. The Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update. Med Res Rev. 2016;36(5):924\u201363. https:\/\/doi.org\/10.1002\/med.21396.","journal-title":"Med Res Rev"},{"issue":"1","key":"2037_CR42","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/med.21925","volume":"43","author":"E Crisman","year":"2023","unstructured":"Crisman E, Duarte P, Dauden E, et al. KEAP1-NRF2 protein-protein interaction inhibitors: design, Pharmacological properties and therapeutic potential. Med Res Rev. 2023;43(1):237\u201387. https:\/\/doi.org\/10.1002\/med.21925.","journal-title":"Med Res Rev"},{"key":"2037_CR43","doi-asserted-by":"publisher","first-page":"5695723","DOI":"10.1155\/2020\/5695723","volume":"2020","author":"X Zhang","year":"2020","unstructured":"Zhang X, Yu Y, Lei H, et al. The Nrf-2\/HO-1 signaling axis: A ray of hope in cardiovascular diseases. Cardiol Res Pract. 2020;2020:5695723. https:\/\/doi.org\/10.1155\/2020\/5695723.","journal-title":"Cardiol Res Pract"},{"issue":"6","key":"2037_CR44","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1179\/096805100101532414","volume":"6","author":"G Zhang","year":"2000","unstructured":"Zhang G, Ghosh S. Molecular mechanisms of NF-kappaB activation induced by bacterial lipopolysaccharide through Toll-like receptors. J Endotoxin Res. 2000;6(6):453\u20137. https:\/\/doi.org\/10.1179\/096805100101532414.","journal-title":"J Endotoxin Res"},{"key":"2037_CR45","doi-asserted-by":"publisher","first-page":"683879","DOI":"10.3389\/fimmu.2021.683879","volume":"12","author":"F He","year":"2021","unstructured":"He F, Wu X, Zhang Q, et al. Bacteriostatic potential of melatonin: therapeutic standing and mechanistic insights. Front Immunol. 2021;12:683879. https:\/\/doi.org\/10.3389\/fimmu.2021.683879. Published 2021 May 31.","journal-title":"Front Immunol"},{"issue":"3","key":"2037_CR46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5492\/wjccm.v12.i3.139","volume":"12","author":"W Nedel","year":"2023","unstructured":"Nedel W, Deutschendorf C, Portela LVC. Sepsis-induced mitochondrial dysfunction: A narrative review. World J Crit Care Med. 2023;12(3):139\u201352. https:\/\/doi.org\/10.5492\/wjccm.v12.i3.139.","journal-title":"World J Crit Care Med"},{"issue":"4","key":"2037_CR47","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00011-021-01447-0","volume":"70","author":"H Yang","year":"2021","unstructured":"Yang H, Zhang Z. Sepsis-induced myocardial dysfunction: the role of mitochondrial dysfunction. Inflamm Res. 2021;70(4):379\u201387. https:\/\/doi.org\/10.1007\/s00011-021-01447-0.","journal-title":"Inflamm Res"},{"issue":"1","key":"2037_CR48","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13054-024-05069-w","volume":"28","author":"D Hu","year":"2024","unstructured":"Hu D, Sheeja Prabhakaran H, Zhang YY, et al. Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives. Crit Care. 2024;28(1):292. https:\/\/doi.org\/10.1186\/s13054-024-05069-w.","journal-title":"Crit Care"},{"key":"2037_CR49","doi-asserted-by":"crossref","unstructured":"Song J, Fang X, Zhou K, Bao H, Li L. Sepsis\u2013induced cardiac dysfunction and pathogenetic mechanisms (Review). Mol Med Rep., Endlicher R, Drahota Z, \u0160tefkov\u00e1 K, \u010cervinkov\u00e1 Z, Ku\u010dera O. The Mitochondrial Permeability [50], Endlicher R, Drahota Z, \u0160tefkov\u00e1 K et al. The Mitochondrial Permeability Transition Pore-Current Knowledge of Its Structure, Function, and Regulation, and Optimized Methods for Evaluating Its Functional State. Cells. 2023;12(9):1273. doi: 10.3390\/cells12091273.","DOI":"10.3390\/cells12091273"},{"issue":"17","key":"2037_CR50","doi-asserted-by":"publisher","first-page":"9627","DOI":"10.1111\/jcmm.15470","volume":"24","author":"M Sep\u00falveda","year":"2020","unstructured":"Sep\u00falveda M, Burgos JI, Ciocci Pardo A, et al. CaMKII-dependent Ryanodine receptor phosphorylation mediates sepsis-induced cardiomyocyte apoptosis. J Cell Mol Med. 2020;24(17):9627\u201337. https:\/\/doi.org\/10.1111\/jcmm.15470.","journal-title":"J Cell Mol Med"},{"key":"2037_CR51","doi-asserted-by":"publisher","first-page":"103049","DOI":"10.1016\/j.redox.2024.103049","volume":"70","author":"MD Pokharel","year":"2024","unstructured":"Pokharel MD, Garcia-Flores A, Marciano D, et al. Mitochondrial network dynamics in pulmonary disease: bridging the gap between inflammation, oxidative stress, and bioenergetics. Redox Biol. 2024;70:103049. https:\/\/doi.org\/10.1016\/j.redox.2024.103049.","journal-title":"Redox Biol"},{"key":"2037_CR52","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.yjmcc.2019.04.006","volume":"130","author":"B Haileselassie","year":"2019","unstructured":"Haileselassie B, Mukherjee R, Joshi AU, et al. Drp1\/Fis1 interaction mediates mitochondrial dysfunction in septic cardiomyopathy. J Mol Cell Cardiol. 2019;130:160\u20139. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.04.006.","journal-title":"J Mol Cell Cardiol"},{"issue":"17","key":"2037_CR53","doi-asserted-by":"publisher","first-page":"9707","DOI":"10.3390\/ijms25179707","volume":"25","author":"M Zhao","year":"2024","unstructured":"Zhao M, Li J, Li Z, et al. SIRT1 regulates mitochondrial damage in N2a cells treated with the prion protein fragment 106\u2013126 via PGC-1\u03b1-TFAM-Mediated mitochondrial biogenesis. Int J Mol Sci. 2024;25(17):9707. https:\/\/doi.org\/10.3390\/ijms25179707.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2037_CR54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12944-023-01798-z","volume":"22","author":"Z Hu","year":"2023","unstructured":"Hu Z, Zhang H, Wang Y, et al. Exercise activates Sirt1-mediated Drp1 acetylation and inhibits hepatocyte apoptosis to improve nonalcoholic fatty liver disease. Lipids Health Dis. 2023;22(1):33. https:\/\/doi.org\/10.1186\/s12944-023-01798-z.","journal-title":"Lipids Health Dis"},{"issue":"2","key":"2037_CR55","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88. https:\/\/doi.org\/10.1038\/s41419-020-2298-2. Published 2020 Feb 3.","journal-title":"Cell Death Dis"},{"issue":"4","key":"2037_CR56","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382. https:\/\/doi.org\/10.1038\/s41580-020-00324-8.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2037_CR57","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.freeradbiomed.2020.08.009","volume":"160","author":"N Li","year":"2020","unstructured":"Li N, Wang W, Zhou H, et al. Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury. Free Radic Biol Med. 2020;160:303\u201318. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.08.009.","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"2037_CR58","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3892\/mmr.2023.13114","volume":"28","author":"J Song","year":"2023","unstructured":"Song J, Fang X, Zhou K, Bao H, Li L. Sepsis\u2013induced cardiac dysfunction and pathogenetic mechanisms (Review). Mol Med Rep. 2023;28(6):227. https:\/\/doi.org\/10.3892\/mmr.2023.13114.","journal-title":"Mol Med Rep"},{"issue":"1","key":"2037_CR59","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","volume":"20","author":"X Fang","year":"2023","unstructured":"Fang X, Ardehali H, Min J, Wang F. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat Rev Cardiol. 2023;20(1):7\u201323. https:\/\/doi.org\/10.1038\/s41569-022-00735-4.","journal-title":"Nat Rev Cardiol"},{"key":"2037_CR60","doi-asserted-by":"publisher","first-page":"115438","DOI":"10.1016\/j.ejmech.2023.115438","volume":"257","author":"L Huo","year":"2023","unstructured":"Huo L, Liu C, Yuan Y, Liu X, Cao Q. Pharmacological Inhibition of ferroptosis as a therapeutic target for sepsis-associated organ damage. Eur J Med Chem. 2023;257:115438. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115438.","journal-title":"Eur J Med Chem"},{"issue":"5","key":"2037_CR61","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3892\/mmr.2022.12851","volume":"26","author":"G Cao","year":"2022","unstructured":"Cao G, Zeng Y, Zhao Y, et al. H2S regulation of ferroptosis attenuates sepsis\u2013induced cardiomyopathy. Mol Med Rep. 2022;26(5):335. https:\/\/doi.org\/10.3892\/mmr.2022.12851.","journal-title":"Mol Med Rep"},{"issue":"4","key":"2037_CR62","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/SHK.0000000000002257","volume":"61","author":"L Guo","year":"2024","unstructured":"Guo L, Li P, Wang Y, YIQIFUMAI INJECTION AMELIORATED SEPSIS-INDUCED CARDIOMYOPATHY BY INHIBITION OF FERROPTOSIS VIA XCT\/GPX4 AXIS, et al. Shock. 2024;61(4):638\u201345. https:\/\/doi.org\/10.1097\/SHK.0000000000002257.","journal-title":"Shock"},{"issue":"3","key":"2037_CR63","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s10753-023-01954-8","volume":"47","author":"JS Lu","year":"2024","unstructured":"Lu JS, Wang JH, Han K, et al. Nicorandil regulates ferroptosis and mitigates septic cardiomyopathy via TLR4\/SLC7A11 signaling pathway. Inflammation. 2024;47(3):975\u201388. https:\/\/doi.org\/10.1007\/s10753-023-01954-8.","journal-title":"Inflammation"},{"key":"2037_CR64","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.freeradbiomed.2022.05.023","volume":"187","author":"J Wang","year":"2022","unstructured":"Wang J, Zhu Q, Wang Y, Peng J, Shao L, Li X. Irisin protects against sepsis-associated encephalopathy by suppressing ferroptosis via activation of the Nrf2\/GPX4 signal axis. Free Radic Biol Med. 2022;187:171\u201384. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.05.023.","journal-title":"Free Radic Biol Med"},{"key":"2037_CR65","doi-asserted-by":"publisher","first-page":"103066","DOI":"10.1016\/j.redox.2024.103066","volume":"70","author":"H Zhang","year":"2024","unstructured":"Zhang H, Pan J, Huang S, et al. Hydrogen sulfide protects cardiomyocytes from doxorubicin-induced ferroptosis through the SLC7A11\/GSH\/GPx4 pathway by Keap1 S-sulfhydration and Nrf2 activation. Redox Biol. 2024;70:103066. https:\/\/doi.org\/10.1016\/j.redox.2024.103066.","journal-title":"Redox Biol"},{"issue":"6","key":"2037_CR66","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1007\/s10565-023-09834-5","volume":"39","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zhang L, Yao G, et al. NRF2 is essential for iron-overload stimulated osteoclast differentiation through regulation of redox and iron homeostasis. Cell Biol Toxicol. 2023;39(6):3305\u201321. https:\/\/doi.org\/10.1007\/s10565-023-09834-5.","journal-title":"Cell Biol Toxicol"},{"issue":"8","key":"2037_CR67","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/aps.2017.143","volume":"39","author":"ST Li","year":"2018","unstructured":"Li ST, Dai Q, Zhang SX, et al. Ulinastatin attenuates LPS-induced inflammation in mouse macrophage RAW264.7 cells by inhibiting the JNK\/NF-\u03baB signaling pathway and activating the PI3K\/Akt\/Nrf2 pathway. Acta Pharmacol Sin. 2018;39(8):1294\u2013304. https:\/\/doi.org\/10.1038\/aps.2017.143.","journal-title":"Acta Pharmacol Sin"},{"key":"2037_CR68","doi-asserted-by":"publisher","first-page":"380218","DOI":"10.1155\/2015\/380218","volume":"2015","author":"X Xu","year":"2015","unstructured":"Xu X, Li H, Hou X, et al. Punicalagin induces Nrf2\/HO-1 expression via upregulation of PI3K\/AKT pathway and inhibits LPS-Induced oxidative stress in RAW264.7 macrophages. Mediators Inflamm. 2015;2015:380218. https:\/\/doi.org\/10.1155\/2015\/380218.","journal-title":"Mediators Inflamm"},{"issue":"2","key":"2037_CR69","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10557-011-6292-x","volume":"25","author":"DL Mann","year":"2011","unstructured":"Mann DL. The emerging role of small non-coding RNAs in the failing heart: big hopes for small molecules. Cardiovasc Drugs Ther. 2011;25(2):149. https:\/\/doi.org\/10.1007\/s10557-011-6292-x.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"2037_CR70","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.3390\/ijms22062904","volume":"22","author":"P Zhu","year":"2021","unstructured":"Zhu P, Chen S, Zhang W, et al. Essential role of Non-Coding RNAs in enterovirus infection: from basic mechanisms to clinical prospects. Int J Mol Sci. 2021;22(6):2904. https:\/\/doi.org\/10.3390\/ijms22062904.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2037_CR71","first-page":"231","volume":"51","author":"S Luo","year":"2021","unstructured":"Luo S, Huang X, Liu S, et al. Long Non-Coding RNA small nucleolar RNA host gene 1 alleviates Sepsis-Associated myocardial injury by modulating the miR-181a-5p\/XIAP Axis in vitro. Ann Clin Lab Sci. 2021;51(2):231\u201340.","journal-title":"Ann Clin Lab Sci"},{"issue":"12","key":"2037_CR72","doi-asserted-by":"publisher","first-page":"6476","DOI":"10.3390\/ijms25126476","volume":"25","author":"K Bindayna","year":"2024","unstructured":"Bindayna K. MicroRNA as Sepsis biomarkers: A comprehensive review. Int J Mol Sci. 2024;25(12):6476. https:\/\/doi.org\/10.3390\/ijms25126476. Published 2024 Jun 12.","journal-title":"Int J Mol Sci"},{"key":"2037_CR73","doi-asserted-by":"publisher","first-page":"111500","DOI":"10.1016\/j.intimp.2024.111500","volume":"128","author":"X Nie","year":"2024","unstructured":"Nie X, Deng W, Zhou H, et al. Long noncoding RNA MCM3AP-AS1 attenuates sepsis-induced cardiomyopathy by improving inflammation, oxidative stress, and mitochondrial function through mediating the miR-501-3p\/CADM1\/STAT3 axis. Int Immunopharmacol. 2024;128:111500. https:\/\/doi.org\/10.1016\/j.intimp.2024.111500.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"2037_CR74","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.bbrc.2015.07.051","volume":"464","author":"WL Xue","year":"2015","unstructured":"Xue WL, Bai X, Zhang L. RhTNFR:Fc increases Nrf2 expression via miR-27a mediation to protect myocardium against sepsis injury. Biochem Biophys Res Commun. 2015;464(3):855\u201361. https:\/\/doi.org\/10.1016\/j.bbrc.2015.07.051.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2037_CR75","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1080\/21655979.2021.1926201","volume":"12","author":"W Song","year":"2021","unstructured":"Song W, Zhang T, Yang N, et al. Inhibition of micro RNA miR-122-5p prevents lipopolysaccharide-induced myocardial injury by inhibiting oxidative stress, inflammation and apoptosis via targeting GIT1. Bioengineered. 2021;12(1):1902\u201315. https:\/\/doi.org\/10.1080\/21655979.2021.1926201.","journal-title":"Bioengineered"},{"key":"2037_CR76","doi-asserted-by":"publisher","unstructured":"Bertozzi G, Ferrara M, Di Fazio A et al. Oxidative Stress in Sepsis: A Focus on Cardiac Pathology. Int J Mol Sci. 2024;25(5):2912. Published 2024 Mar 2. https:\/\/doi.org\/10.3390\/ijms25052912","DOI":"10.3390\/ijms25052912"},{"issue":"3","key":"2037_CR77","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/jpp\/rgac102","volume":"75","author":"A Liu","year":"2023","unstructured":"Liu A, Xun S, Zhou G, et al. Honokiol alleviates sepsis-associated cardiac dysfunction via attenuating inflammation, apoptosis and oxidative stress. J Pharm Pharmacol. 2023;75(3):397\u2013406. https:\/\/doi.org\/10.1093\/jpp\/rgac102.","journal-title":"J Pharm Pharmacol"},{"key":"2037_CR78","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2147\/JIR.S428305","volume":"17","author":"W Li","year":"2024","unstructured":"Li W, Lin M, Li J, et al. Xijiao Dihuang Decoction protects against murine Sepsis-Induced cardiac inflammation and apoptosis via suppressing TLR4\/NF-\u03baB and activating PI3K\/AKT pathway. J Inflamm Res. 2024;17:853\u201363. https:\/\/doi.org\/10.2147\/JIR.S428305. Published 2024 Feb 8.","journal-title":"J Inflamm Res"},{"issue":"10","key":"2037_CR79","doi-asserted-by":"publisher","first-page":"597","DOI":"10.21037\/atm-22-836","volume":"10","author":"L Zhao","year":"2022","unstructured":"Zhao L, Jin L, Luo Y, et al. Shenfu injection attenuates cardiac dysfunction and inhibits apoptosis in septic mice. Ann Transl Med. 2022;10(10):597. https:\/\/doi.org\/10.21037\/atm-22-836.","journal-title":"Ann Transl Med"},{"key":"2037_CR80","doi-asserted-by":"publisher","first-page":"117599","DOI":"10.1016\/j.jep.2023.117599","volume":"322","author":"P Huang","year":"2024","unstructured":"Huang P, Guo Y, Hu X, et al. Mechanism of Shenfu injection in suppressing inflammation and preventing sepsis-induced apoptosis in murine cardiomyocytes based on network Pharmacology and experimental validation. J Ethnopharmacol. 2024;322:117599. https:\/\/doi.org\/10.1016\/j.jep.2023.117599.","journal-title":"J Ethnopharmacol"},{"key":"2037_CR81","doi-asserted-by":"publisher","unstructured":"Xu X, Liu Q, He S et al. Qiang-Xin 1 Formula Prevents Sepsis-Induced Apoptosis in Murine Cardiomyocytes by Suppressing Endoplasmic Reticulum- and Mitochondria-Associated Pathways. Front Pharmacol. 2018;9:818. Published 2018 Jul 30. https:\/\/doi.org\/10.3389\/fphar.2018.00818","DOI":"10.3389\/fphar.2018.00818"},{"key":"2037_CR82","doi-asserted-by":"publisher","first-page":"155597","DOI":"10.1016\/j.phymed.2024.155597","volume":"129","author":"SM Lu","year":"2024","unstructured":"Lu SM, Yang B, Tan ZB, et al. TaoHe ChengQi Decoction ameliorates sepsis-induced cardiac dysfunction through anti-ferroptosis via the Nrf2 pathway. Phytomedicine. 2024;129:155597. https:\/\/doi.org\/10.1016\/j.phymed.2024.155597.","journal-title":"Phytomedicine"},{"key":"2037_CR83","doi-asserted-by":"publisher","unstructured":"Sun Z, Yu C, Zhang Z, et al. Efficacy of melatonin as adjunctive therapy for sepsis: A meta-analysis of randomized controlled trials. Complement Ther Med Published Online Febr. 2025;21. https:\/\/doi.org\/10.1016\/j.ctim.2025.103147.","DOI":"10.1016\/j.ctim.2025.103147"},{"issue":"1","key":"2037_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40119-021-00216-8","volume":"10","author":"M Medvegy","year":"2021","unstructured":"Medvegy M, Simonyi G. Supplementary therapeutic possibilities to alleviate myocardial damage due to microvascular dysfunction in coronavirus disease 2019 (COVID-19). Cardiol Ther. 2021;10(1):1\u20137. https:\/\/doi.org\/10.1007\/s40119-021-00216-8.","journal-title":"Cardiol Ther"},{"issue":"2","key":"2037_CR85","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3390\/biom15020286","volume":"15","author":"W Lai","year":"2025","unstructured":"Lai W, Liu L, Wang S, et al. Integrated omics insights into Dapagliflozin effects in Sepsis-Induced cardiomyopathy. Biomolecules. 2025;15(2):286. https:\/\/doi.org\/10.3390\/biom15020286.","journal-title":"Biomolecules"},{"key":"2037_CR86","doi-asserted-by":"publisher","first-page":"1024535","DOI":"10.3389\/fpubh.2022.1024535","volume":"10","author":"A Mumtaz","year":"2022","unstructured":"Mumtaz A, Rehman E, Rahaman MA, et al. Inflammatory biomarkers and cardiac injury in COVID-19 patients. Front Public Health. 2022;10:1024535. https:\/\/doi.org\/10.3389\/fpubh.2022.1024535.","journal-title":"Front Public Health"},{"issue":"3","key":"2037_CR87","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/14787210.2020.1822737","volume":"19","author":"A Tajbakhsh","year":"2021","unstructured":"Tajbakhsh A, Gheibi Hayat SM, Taghizadeh H, et al. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Rev Anti Infect Ther. 2021;19(3):345\u201357. https:\/\/doi.org\/10.1080\/14787210.2020.1822737.","journal-title":"Expert Rev Anti Infect Ther"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02037-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02037-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02037-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:55:46Z","timestamp":1767200146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02037-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2037"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02037-0","relation":{"references":[{"id-type":"doi","id":"10.3389\/fimmu.2018.02015","asserted-by":"subject"}]},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of competing interest"}}],"article-number":"76"}}